Cited by 198Yeasts and Rust Fungi StudiesFungal and yeast genetics researchAntifungal resistance and susceptibility

Comparative genomics of emerging pathogens in the Candida glabrata clade.

Open access
Gabaldón, Toni, Martin, Tiphaine, Marcet-Houben, Marina, Durrens, Pascal, Bolotin-Fukuhara, Monique, Lespinet, Olivier, Arnaise, Sylvie, Boisnard, Stéphanie +22 more·2013·BMC Genomics

Abstract

BACKGROUND: Candida glabrata follows C. albicans as the second or third most prevalent cause of candidemia worldwide. These two pathogenic yeasts are distantly related, C. glabrata being part of the Nakaseomyces, a group more closely related to Saccharomyces cerevisiae. Although C. glabrata was thought to be the only pathogenic Nakaseomyces, two new pathogens have recently been described within this group: C. nivariensis and C. bracarensis. To gain insight into the genomic changes underlying the emergence of virulence, we sequenced the genomes of these two, and three other non-pathogenic Nakaseomyces, and compared them to other sequenced yeasts. RESULTS: Our results indicate that the two new pathogens are more closely related to the non-pathogenic N. delphensis than to C. glabrata. We uncover duplications and accelerated evolution that specifically affected genes in the lineage preceding the group containing N. delphensis and the three pathogens, which may provide clues to the higher propensity of this group to infect humans. Finally, the number of Epa-like adhesins is specifically enriched in the pathogens, particularly in C. glabrata. CONCLUSIONS: Remarkably, some features thought to be the result of adaptation of C. glabrata to a pathogenic lifestyle, are present throughout the Nakaseomyces, indicating these are rather ancient adaptations to other environments. Phylogeny suggests that human pathogenesis evolved several times, independently within the clade. The expansion of the EPA gene family in pathogens establishes an evolutionary link between adhesion and virulence phenotypes. Our analyses thus shed light onto the relationships between virulence and the recent genomic changes that occurred within the Nakaseomyces. SEQUENCE ACCESSION NUMBERS: Nakaseomyces delphensis: CAPT01000001 to CAPT01000179Candida bracarensis: CAPU01000001 to CAPU01000251Candida nivariensis: CAPV01000001 to CAPV01000123Candida castellii: CAPW01000001 to CAPW01000101Nakaseomyces bacillisporus: CAPX01000001 to CAPX01000186.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-2164-14-623

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The CTG clade comprises the majority of Candida species and forms a monophyletic group of yeasts that exhibit a genetic code transition, causing the codon CTG to be translated as serine instead of leucine.

    “The CTG clade comprises the majority of Candida species and forms a monophyletic group of yeasts that exhibit a genetic code transition, causing the codon CTG to be translated as serine instead of leucine [60–62]”

    From Competition assays and physiological experiments of soil and phyllosphere yeasts identify Candida subhashii as a novel antagonist of filamentous fungi (2017) · cites this paper as [61]

    The Results section (Phylogeny of Nakaseomyces; page unavailable) identifies a genetic-code transition in the Candida CTG clade. Our copy does not establish that the clade contains a majority of Candida species or specify that CTG is translated as serine rather than leucine. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • The C. glabrata genome harbors several members of a specific gene family encoding epithelial adhesin proteins (EPA genes), which are considered a key factor in its ability to infect humans.

    “The C. glabrata genome harbors several members of a specific gene family encoding epithelial adhesin proteins (EPA genes), which are considered a key factor in its ability to infect humans (Cormack and Falkow, 1999; Roetzer et al., 2011; Gabaldón et al., 2013; Vale-Silva et al., 2017).”
  • C. glabrata may have acquired a unique set of pathogenesis attributes.

    “As the capability to infect humans appears to have emerged independently within the Nakaseomyces [18], C. glabrata may have acquired a unique set of pathogenesis attributes.”

    From Candida glabrata: A Lot More Than Meets the Eye (2019) · cites this paper as [18]

  • Molecular phylogenetic and genome analysis have revealed that the three human pathogenic species of the glabrata group, C. glabrata, C. nivariensis and C. bracarenses, are polyphyletic in origin.

    “Intriguingly, molecular phylogenetic and genome analysis have revealed three human pathogenic species, C. glabrata, C. nivariensis and C. bracarenses of the glabrata group, to be polyphyletic in origin [18,25].”

    From Candida glabrata: A Lot More Than Meets the Eye (2019) · cites this paper as [18]

  • Evolutionarily, C. glabrata is closer to the non-pathogenic yeast Saccharomyces cerevisiae than to C. albicans.

    “Evolutionarily, it is closer to the non-pathogenic yeast Saccharomyces cerevisiae than to the most prevalent Candida bloodstream pathogen, C. albicans.”

    From Candida glabrata: A Lot More Than Meets the Eye (2019) · cites this paper as [18]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 95 · Cited by 198

Research works printed but not linked: 2

  1. Hauswirth WW Lim LO Dujon B Turner G Darley-Usmar VM, Rickwood D, Wilson MT Methods for studying the genetics of mitochondria Mitochondria: A Pratical Approach 1987 Oxford: IRL Press 171 244
  2. Akaike H Information and an extension of the maximumlikehood principle Second International Symposium on Information Theory 1973 Budapest (Hungary): Akademiai Kiado 267 281

Authors
Gabaldón, T., Martin, T., Marcet-Houben, M., Durrens, P., Bolotin-Fukuhara, M., Lespinet, O., Arnaise, S., Boisnard, S., Aguileta, G., Atanasova, R., Bouchier, C., Couloux, A., Creno, S., Almeida Cruz, J., Devillers, H., Enache-Angoulvant, A., Guitard, J., Jaouen, L., Ma, L., Marck, C., Neuvéglise, C., Pelletier, E., Pinard, A., Poulain, J., Recoquillay, J., Westhof, E., Wincker, P., Dujon, B., Hennequin, C., & Fairhead, C.
Affiliations
  • Universitat Pompeu Fabra (ES)
  • Institut national de recherche en sciences et technologies du numérique (FR)
  • Université Paris-Sud (FR)
  • Inserm (FR)
  • Institut Pasteur (FR)
  • Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
  • Institut de Biologie et Technologies (FR)
  • Institut National de la Recherche Agronomique (FR)
  • Centre National de la Recherche Scientifique (FR)
Corresponding author
Gabaldón, Toni
Venue
BMC Genomics
Published
2013
Volume
14
Issue
1
Pages
623
ISSN
1471-2164 (ISSN-L)
OpenAlex
W2132309217
Cited by
198
References
95
Citations by year
2026: 9 · 2025: 11 · 2024: 17 · 2023: 9 · 2022: 19 · 2021: 18 · 2020: 16 · 2019: 21 · 2018: 20 · 2017: 15 · 2016: 11 · 2015: 22 · 2014: 10
FWCI
6.42
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • BMC Genomics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RECERCAT (Consorci de Serveis Universitaris de Catalunya) (publishedVersion, other-oa)
  • Repositori digital de la UPF (Universitat Pompeu Fabra) (publishedVersion, cc-by)
  • HAL (submittedVersion)
  • HAL (submittedVersion, cc-by)
  • Oskar-Bordeaux (Universite de Bordeaux) (submittedVersion, cc-by)
  • univOAK (4 institutions : Université de Strasbourg, Université de Haute Alsace, INSA Strasbourg, Bibliothèque Nationale et Universitaire de Strasbourg) (submittedVersion, cc-by)
Funders
  • European Commission (2007–2013, FP7-PEOPLE-2010-IEF, 274223, FP/2007-2013)/ERC, FP/2007/2013)
  • Fonds National de la Recherche Luxembourg
  • Ministerio de Economía y Competitividad (BIO2012-37161)
  • Qatar National Research Fund (5-298-3-086, NPRP 5‐298‐3‐086)
  • FP7 Ideas: European Research Council (310325)
  • FP7 People: Marie-Curie Actions (2007-2013)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Yeasts and Rust Fungi Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Keywords
Candida glabrata, Candida nivariensis, Candida bracarensis, emerging fungal pathogens, candidemia, virulence evolution, gene family expansion, gene duplication, phylogeny, comparative genomics
MeSH terms
DNA, Fungal, Saccharomycetales, Phylogeny, Selection, Genetic, Genome, Fungal, Sequence Analysis, DNA, Evolution, Molecular, Candida glabrata

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review